Key result
Baseline plasma tetranectin levels are ~32% lower in AMI patients compared to healthy controls.
Observational (n=90)
Answers are grounded in this paper and cite their sources.
Randomized trial assesses tetranectin changes in acute myocardial infarction, indicating its role in fibrinolysis.
Tetranectin (TN), a new regulator of fibrinolysis, was studied in the plasma of 60 patients with acute myocardial infarction (AMI) and 30 healthy subjects (HS), in relation to D-dimer (DD) and alpha 2-plasmin inhibitor (alpha 2-PI), to investigate its possible involvement in the pathophysiology of AMI. Thirty patients underwent thrombolytic treatment with fibrin-specific plasminogen activator (rt-PA) (group A); the other 30 patients, according to the exclusion criteria, were conventionally treated (group B). Twenty of the thrombolysized patients established early recanalization (subgroup A1), while 10 failed to respond to thrombolytic treatment (subgroup A2). Median (interquartile range), baseline plasma TN levels were lower in AMI patients compared to HS [8.27 (2.75) mg/L versus 12.1 (0.55) mg/L, P < 10(-6)]. In subgroup A1, TN increased at the end of rt-PA infusion and returned to the baseline levels 12 h later. A positive association between DD and TN release (3 h level minus baseline level) was found (rs = 0.48, P = 0.03) in subgroup A1. No significant alterations of TN levels were observed during therapy in subgroup A2 and group B. TN, DD and alpha 2-PI concentrations in group B remained relatively constant during the study period. This study provides evidence of a significant decrease of TN levels in AMI patients compared to healthy subjects and of a remarkable difference in the evolution of TN levels during thrombolytic treatment with rt-PA between recanalized and non-recanalized AMI patients. Thus, an involvement of TN in the formation and dissolution of fibrin clot in AMI patients is worthy of further investigation.
No takes yet. Share an insight, caveat, or question.
Kamper et al. (1998) conducted an observational in Acute myocardial infarction (n=90). Acute myocardial infarction vs. Healthy subjects was evaluated on Baseline plasma tetranectin levels (mg/L) (p=< 10(-6)). Baseline plasma tetranectin levels were lower in AMI patients compared to healthy subjects and increased transiently after successful recanalization.
Synapse has enriched 10 related papers. Consider them for comparative context: